Neuroimaging, AI help detect brain changes

UC researchers co-lead NIMH-funded study of children of bipolar parents

Researchers at the University of Cincinnati and Dell Medical School at the University of Texas at Austin (Dell Med) are leading a study using state-of-the-art neuroimaging techniques and artificial intelligence to identify changes in the brains among children of adults living with bipolar disorder — a debilitating condition that interferes with daily life due to its dramatic mood, energy and activity level shifts. 

Almost 3% of U.S. adults live with bipolar disorder, one of the leading causes of disability worldwide. The highest risk factor for bipolar disorder is having a close family member with the condition.  

The study is co-led by UC’s Melissa DelBello, MD; Jorge Almeida, MD, and Charles Nemeroff, MD, PhD of Dell Med and Indiana University’s Stephen Strakowski, MD. 

Melissa Delbello Psychiatry

Melissa DelBello, MD. Photo/University of Cincinnati.

“We are hoping to clarify how stress and trauma impact brain development in children and adolescents who have a family risk for bipolar disorder,” said DelBello, the Dr. Stanley and Mickey Kaplan Endowed Chair and Professor in the Department of Psychiatry and Behavioral Neuroscience at UC’s College of Medicine. “This work is the next step in studying risk and resilience factors associated with bipolar disorder.”   

The brain’s inability to “hit the brakes” on energy delivered by its reward system results in manic behaviors such as spending too much money, engaging in risky behaviors and sleep loss or disruption, said Almeida, director of the Bipolar Disorder Center at Mulva Clinic for the Neurosciences and associate professor in the Department of Psychiatry and Behavioral Sciences at Dell Med.  

The study is the first of its kind to focus specifically on the progression of the disease over time via neuroimaging in children of parents with bipolar disorder. 

The research leverages AI algorithms to discern variations in participants’ brains, combining imaging data with cognitive, clinical, early life adversity and psychosocial function measures. The result is a precise delineation of brain maturation for each person at risk of developing bipolar disorder. 

This study will increase our understanding of the onset of bipolar disorder and ultimately help us identify effective strategies to intervene early or prevent the onset of the illness.

Melissa DelBello, MD

The five-year longitudinal study uses functional magnetic resonance imaging to identify early signs that the brain is developing bipolar disorder. Participants ages 14-21 — a critical time when mania symptoms often develop — undergo annual brain scans to track changes in the brain. If they become depressed, suicidal or experience mania, the participants undergo additional brain scans to help researchers understand how the damage is unfolding. 

Participants also undergo mood assessments and are required to perform tasks that activate and test the brain’s reward system. 

“This study will increase our understanding of the onset of bipolar disorder and ultimately help us identify effective strategies to intervene early or prevent the onset of the illness,” DelBello said. 

“This study evokes hope for me,” Almeida said. “Hope that we finally have the tools to help this condition and possibly prevent it from ever happening.”  

Impact Lives Here

The University of Cincinnati is leading public urban universities into a new era of innovation and impact. Our faculty, staff and students are saving lives, changing outcomes and bending the future in our city's direction. Next Lives Here.

In its third year of a five-year grant, the research is funded by the National Institute of Mental Health. Additional investigators on the project at UC include David Fleck, PhD, Kelly Cohen, PhD, Cal Adler, MD, and L Rodrigo Patino Duran, MD.  

A version of this story was first published in the Dell Med newsroom.

Featured photo at top of brain scans. Photo/Nur Ceren Demir/iStock.

Related Stories

9183 Results
1

President picks exceptional talent

April 28, 2021

The University of Cincinnati 2021 Presidential Leadership Medal of Excellence Awards honor six undergraduate scholars for scholarship, leadership, character, service and the ideals of the university. Awardees are spotlighted for exceptional academics, creativity, community service and innovation.

2

Grad students earn president's highest honor

April 28, 2021

The University of Cincinnati 2021 Presidential Medal of Graduate Student Excellence Awards honor three graduate scholars for scholarship, leadership, character, service and the ideals of the university. Awardees are spotlighted for exceptional academics, creativity, community service and innovation.

3

Local 12: 180 UC med students receive white coats, students embark on journey during pandemic

August 9, 2021

The University of Cincinnati College of Medicine welcomed 180 newly admitted first-year students during the college’s 26th annual White Coat Ceremony. The ceremony was held Friday at 10 a.m. at Cincinnati Music Hall, 1241 Elm Street. Each member of the class of 2025 were presented with a white lab coat, symbolizing entry into the medical profession. Local 12 covered the event.

4

Finding community and building a future

July 9, 2021

As a University of Cincinnati College of Medicine student, Sarah Appeadu, MD, ’21, remembers journaling on the “3 Cs” that got her through medical school: Community, community, community. Now, when she lists the people who supported her through four years of training—the last year in a global pandemic—it keeps growing: her family, her church, her classmates, and the college’s Office of Student Affairs and Office of Diversity, Equity and Inclusion. “I look back and it was such a crucial time to really be nurtured in that way,” she says. “I’m so thankful that I had those people. It shows being around the right people really mattered. That’s my same hope for residency even.”

8

UC Receives $1.9 Million to Study Pain

February 15, 2016

Jun-Ming Zhang, MD, of the UC College of Medicine, is the principal investigator of a $1.95 million grant to study the interacting roles of the sympathetic and sensory nervous and immune systems in back and neuropathic pain models.

9

MD Magazine: Generic Drug Equally Effective in Epilespy

February 22, 2016

Michael Privitera, MD, a professor of neurology at UC's College of Medicine and director of the Epilepsy Center at the UC Neuroscience Institute, is featured in this story about research he led that examined the efficacy of generic drug substitution for epilepsy.